Liver Neoplasms: all 1,406 studies
Page 7 of 15. Open to participants first (347), then studies with results posted, then the rest; newest registration first within each.
- Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)WithdrawnNCT05641922Not applicable
- Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver CancersStatus unknownNCT05622825Phase 1/2
- Dose-escalation of Regorafenib in Advanced Hepatocellular CarcinomaActive, not recruitingNCT05622136Phase 2
- Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving ImmunotherapyStatus unknownNCT05620004Phase 1/2
- I-FIGS Feasibility StudyCompletedNCT05616039Not applicable
- Analysis of Clinical Outcomes and Complications in Patients Received Liver Transplantation: A Retrospective StudyStatus unknownNCT05587556
- Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation ProceduresTerminatedNCT05582018Not applicable
- TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver CancerStatus unknownNCT05550025Phase 2
- Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular CarcinomaCompletedNCT05540925
- HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCCCompletedNCT05532319Phase 2
- Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver MetastasisStatus unknownNCT05524155Phase 2
- Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)Active, not recruitingNCT05520099
- A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC OncogeneTerminatedNCT05497453Phase 1/2
- Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic TumorsCompletedNCT05495529
- The PLATON NetworkTerminatedNCT05489250
- Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classesCompletedNCT05475054
- Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver MetastasisCompletedNCT05462470
- Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With AnlotinibStatus unknownNCT05453383Phase 2
- A Multicenter, Randomized, Parallel-controlled Clinical Trial Protocol to Validate the Safety and Efficacy of a Steep Pulse Therapy System for the Treatment of Liver TumorsStatus unknownNCT05451160Not applicable
- No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet ElectrodesStatus unknownNCT05449873Not applicable
- Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet ElectrodesStatus unknownNCT05449860Not applicable
- Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency AblationCompletedNCT05445973Not applicable
- Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsActive, not recruitingNCT05438420Phase 1/2
- Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CTCompletedNCT05430841Not applicable
- A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid TumorsTerminatedNCT05427396Phase 1
- A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in ArizonaWithdrawnNCT05418387Not applicable
- IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver CancerStatus unknownNCT05411757Early Phase 1
- Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer PatientsCompletedNCT05411133Phase 1
- Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene StatusStatus unknownNCT05409417Phase 2/3
- Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line TherapyStatus unknownNCT05406206Phase 2
- Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver CancerStatus unknownNCT05383066
- A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)TerminatedNCT05375604Phase 1
- A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver CancerActive, not recruitingNCT05371873
- Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet VentilationCompletedNCT05370001Not applicable
- To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in PatientsStatus unknownNCT05369650Not applicable
- Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour ResectionCompletedNCT05361252Not applicable
- Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical ProcedureStatus unknownNCT05360420Not applicable
- International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid BiopsyTerminatedNCT05342350
- Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCActive, not recruitingNCT05301842Phase 3
- A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsCompletedNCT05293496Phase 1
- Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver CancerWithdrawnNCT05292443
- Nutrition and Exercise Prehabilitation to Reduce Morbidity Following Major Liver Surgery in Sarcopenic PatientsCompletedNCT05281211Not applicable
- Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.CompletedNCT05273489
- Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter TrialStatus unknownNCT05268549
- CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver MetastasesCompletedNCT05261113
- Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic PlatformStatus unknownNCT05242237
- Treat Primary and Metastatic Liver TumorsWithdrawnNCT05240040
- A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) ParticipantsCompletedNCT05225207
- TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver CancerStatus unknownNCT05220020Phase 3
- Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver TumorsWithdrawnNCT05211388Not applicable
- A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver CancerActive, not recruitingNCT05211323Phase 2
- Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
- Clinical Validation of a Fractional Administration Device for Holmium-166 SIRTCompletedNCT05183776Not applicable
- Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver MetastasisStatus unknownNCT05183425
- Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
- Composition for Treating Cirrhosis and Liver Cancer (SB-1121)CompletedNCT05178303Phase 4
- Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma PatientsCompletedNCT05171335Phase 2
- Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in InfantsStatus unknownNCT05170282
- Impact of Blood Salvage Therapy on Outcomes After Oncologic Liver SurgeryCompletedNCT05164406
- Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path PlanningStatus unknownNCT05161624
- Perioperative Intravenous Lidocaine in Liver SurgeryCompletedNCT05153785Phase 2/3
- Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsCompletedNCT05146297Not applicable
- Pressure-enabled Delivery in Radioembolization (TriNav Study)CompletedNCT05128032Not applicable
- Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver TumorsStatus unknownNCT05123209Phase 1
- Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular CarcinomaWithdrawnNCT05109052Phase 1/2
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid TumorsActive, not recruitingNCT05103631Phase 1
- Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular CarcinomaCompletedNCT05100082
- Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
- ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskActive, not recruitingNCT05064553
- TheraSphere With Durvalumab and Tremelimumab for HCCActive, not recruitingNCT05063565Phase 2
- Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)CompletedNCT05044065Not applicable
- Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
- A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line TherapyWithdrawnNCT05039736Phase 2
- Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLMCompletedNCT05036265
- Immunotherapy for Advanced Liver CancerSuspendedNCT05033522Phase 2/3
- Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver CancerStatus unknownNCT05032014Not applicable
- Integrative Nutrition Care Plan for the Patient With Liver and Colorectal CancerCompletedNCT05030090Not applicable
- External Validation of the Apfel Risk Score and Koivuranta Score to Predict Postoperative Nausea and Vomiting in Patients With Liver CancerStatus unknownNCT05014737
- ALPPS Combined With Tislelizumab in Liver MalignancyStatus unknownNCT04996446Phase 2
- TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular CarcinomaActive, not recruitingNCT04988945Phase 2
- Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After SurgeryCompletedNCT04962958Phase 2
- Anlotinib for Hepatocellular CarcinomaStatus unknownNCT04954521
- Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver MetastasisStatus unknownNCT04912258Phase 3
- Registry to Collect Health Information Related to Fibrolamellar CancerCompletedNCT04874519
- Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPSCompletedNCT04868149Not applicable
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)CompletedNCT04825834
- Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot StudyStatus unknownNCT04817813
- Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and PancreasStatus unknownNCT04813432
- Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesTerminatedNCT04785287Phase 1/2
- Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver TumorsStatus unknownNCT04764409
- 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver MetastasesStatus unknownNCT04755907
- Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)Active, not recruitingNCT04751773Not applicable
- Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma PatientsActive, not recruitingNCT04736121Not applicable
- DNX-2440 for Resectable Colorectal Liver MetastasisSuspendedNCT04714983Phase 1
- Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) TherapyCompletedNCT04707547Phase 4
- Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial RadioembolizationTerminatedNCT04702230
- Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic CancersCompletedNCT04692454Not applicable
- Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cmStatus unknownNCT04686942
- Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic CancersActive, not recruitingNCT04682847
- Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver MetastasesCompletedNCT04682665